166 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
Street, Appt 20, Philadelphia PA 19106 (“Employee”).
WHEREAS the Company and Employee desire to enter into this Agreement to establish and govern … . Employment. The Company agrees to employ Employee and Employee agrees to provide services to the Company from January 13, 2020 (“Commencement
8-K
EX-14.1
ADAP
Adaptimmune Therapeutics Plc
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
and employees of the Company, whether they work for the Company on a full-time, part-time or temporary basis (each, an “employee” and collectively … occurs when an employee’s private interest interferes, or appears to interfere, in any way with the interests of the Company as a whole. An employee
10-K
2016 FY
EX-10.21
ADAP
Adaptimmune Therapeutics Plc
13 Mar 17
Annual report
12:00am
location. This Policy is intended to be a top hat welfare benefit plan under the U.S. Employee Retirement Income Security Act of 1974, as amended (“ERISA … ; and (D) any amount earned, accrued and arising from Executive’s participation in, or benefits accrued under, any Company employee benefit plan
S-8 POS
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Registration of securities for employees (post-effective amendment)
4:54pm
Limited Company Share Option Plan
Adaptimmune Therapeutics plc 2015 Share Option Scheme
Adaptimmune Therapeutics plc 2016 Employee Share Option … Therapeutics plc 2016 Employee Share Option Scheme and Adaptimmune Therapeutics plc Company Share Option Plan.
These Amendments are being filed solely
S-8 POS
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Registration of securities for employees (post-effective amendment)
4:48pm
Limited Company Share Option Plan
Adaptimmune Therapeutics plc 2015 Share Option Scheme
Adaptimmune Therapeutics plc 2016 Employee Share Option … Therapeutics plc 2016 Employee Share Option Scheme and Adaptimmune Therapeutics plc Company Share Option Plan.
These Amendments are being filed solely
8-K
EX-10.2
sjeb0ao
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
e8xnxc jt6ga
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
S-8
msjdu4
30 Aug 19
Registration of securities for employees
12:30pm
8-K
EX-10.2
vvqco4h98vjvdz2ie
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
j6uzab i60sz1j7kdf9
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
S-8
1ito9r3k94pz0v724bz8
30 Nov 23
Registration of securities for employees
4:16pm